127 related articles for article (PubMed ID: 856607)
1. Effects of mazindol and d-fenfluramine of 5-hydroxytryptamine uptake, storage and metabolism in blood platelets.
Picotti GB; Carruba MO; Zambotti F; Mantegazza P
Eur J Pharmacol; 1977 Apr; 42(3):217-24. PubMed ID: 856607
[TBL] [Abstract][Full Text] [Related]
2. Effects of mazindol, fenfluramine and chlorimipramine on the 5-hydroxytryptamine uptake and storage mechanisms in rat brain: similarities and differences.
Carruba MO; Picotti GB; Zambotti F; Mantegazza P
Naunyn Schmiedebergs Arch Pharmacol; 1977 Nov; 300(3):227-32. PubMed ID: 600310
[TBL] [Abstract][Full Text] [Related]
3. Effect of fenfluramine on 5-hydroxytryptamine uptake and release by rat blood platelets.
Buczko W; De Gaetano G; Garattini S
Br J Pharmacol; 1975 Apr; 53(4):563-8. PubMed ID: 1148499
[TBL] [Abstract][Full Text] [Related]
4. Interference by fenfluramine with the storage of 14C-5-hydroxytryptamine in rat platelets.
Wielosz M; Roncaglioni MC; de Gaetano G; Garattini S
Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):232-9. PubMed ID: 849072
[TBL] [Abstract][Full Text] [Related]
5. Role of brain monoamines in the anorectic activity of mazindol and d-amphetamine in the rat.
Samanin R; Bendotti C; Bernasconi S; Borroni E; Garattini S
Eur J Pharmacol; 1977 May; 43(2):117-24. PubMed ID: 872869
[TBL] [Abstract][Full Text] [Related]
6. The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
Johnson GJ; Leis LA; Dunlop PC; Weir EK
J Thromb Haemost; 2003 Dec; 1(12):2663-8. PubMed ID: 14675103
[TBL] [Abstract][Full Text] [Related]
7. Uptake of 14C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition. A comparative kinetic analysis.
Wielosz M; Salmona M; de Gaetano G; Garattini S
Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):59-65. PubMed ID: 1012348
[TBL] [Abstract][Full Text] [Related]
8. Uptake of 5-hydroxytryptamine in blood platelets and its inhibition by drugs: role of plasma membrane and granular storage.
Laubscher A; Pletscher A
J Pharm Pharmacol; 1979 May; 31(5):284-9. PubMed ID: 37296
[TBL] [Abstract][Full Text] [Related]
9. Effects of spiperone on feeding parameters in the rat and interactions with (+)-amphetamine, mazindol or (+/-)-fenfluramine [proceedings].
Cooper SJ; Sweeney KF
Br J Pharmacol; 1979 May; 66(1):147P-148P. PubMed ID: 454939
[No Abstract] [Full Text] [Related]
10. Vitamin C and weight reducing drugs on brain ascorbic acid in guinea pigs.
Odumosu A
Acta Vitaminol Enzymol; 1981; 3(2):96-102. PubMed ID: 7325103
[TBL] [Abstract][Full Text] [Related]
11. Some effects of mazindol, an anorectic drug, on rat brain monoaminergic systems.
Sugrue MF; Shaw G; Charlton KG
Eur J Pharmacol; 1977 Apr; 42(4):379-85. PubMed ID: 856614
[TBL] [Abstract][Full Text] [Related]
12. On the role of serotonin in the pathogenesis of pulmonary hypertension induced by anorectic drugs; an experimental study in the isolated perfused rat lung, II. Fenfluramine, mazindol, mefenorex, phentermine and R 800.
Seiler KU; Wassermann O; Wensky H
Clin Exp Pharmacol Physiol; 1976; 3(4):323-30. PubMed ID: 975621
[TBL] [Abstract][Full Text] [Related]
13. Ciclazindol and mazindol on glucose uptake into human isolated skeletal muscle: no interaction of mazindol with methysergide.
Kirby MJ; Turner P
Br J Clin Pharmacol; 1977 Aug; 4(4):459-61. PubMed ID: 901738
[TBL] [Abstract][Full Text] [Related]
14. Subjective effects of two anorexigenic agents--fenfluramine and AN 448 in normal subjects.
Holmstrand J; Jonsson J
Postgrad Med J; 1975; 51 Suppl 1():183-6. PubMed ID: 768967
[No Abstract] [Full Text] [Related]
15. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
16. Anorectic drugs and vitamin C: role in appetite and brain ascorbic acid in guineapigs.
Odumosu A
Int J Vitam Nutr Res; 1981; 51(3):247-53. PubMed ID: 7319724
[TBL] [Abstract][Full Text] [Related]
17. Effects of mazindol, a non-phenylethylamine anorexigenic agent, on biogenic amine levels and turnover rate.
Carruba MO; Groppetti A; Mantegazza P; Vicentini L; Zambotti F
Br J Pharmacol; 1976 Apr; 56(4):431-6. PubMed ID: 1260223
[TBL] [Abstract][Full Text] [Related]
18. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.
Schuldiner S; Steiner-Mordoch S; Yelin R; Wall SC; Rudnick G
Mol Pharmacol; 1993 Dec; 44(6):1227-31. PubMed ID: 7903417
[TBL] [Abstract][Full Text] [Related]
19. Chronic fenfluramine administration increases plasma serotonin (5-hydroxytryptamine) to nontoxic levels.
Zolkowska D; Baumann MH; Rothman RB
J Pharmacol Exp Ther; 2008 Feb; 324(2):791-7. PubMed ID: 18032571
[TBL] [Abstract][Full Text] [Related]
20. Plasma free 5-hydroxytryptamine (5-HT): evidence of an increase induced by LM 5008, a potent 5-HT uptake inhibitor.
Uzan A; Le Fur G; Kabouche M; Mitrani N
Life Sci; 1978 Oct; 23(13):1317-24. PubMed ID: 723426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
